Biggest News Aggregation in the World
📰 For Global News

For Global News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from For Global. Real-time updates on events, politics, business and more.

Wexford authors Eoin Colfer and Serena Molloy shortlisted for prestigious children's books award

Wexford authors Serena Molly and Eoin Colfer have been shortlisted for the 2024 KPMG Children’s Books Ireland Awards. In Eoin’s case, he has received nominations for two of his works, Global and Three Tasks for a Dragon. Originally from Wexford, Published by Walker Books and illustrated by P.J. Lynch, Three Tasks for a Dragon follows unlikely hero Prince Lir and not-so-helpless maiden Cethlenn.
United Kingdom New York United States Northern Ireland Pj Lynch Walker Eoin Colfer

Junshi Biosciences Announces Toripalimab's NDA Accepted by the Singapore Health Sciences Authority -February 01, 2024 at 10:41 pm EST

SHANGHAI, China, Feb. 01, 2024 -- Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of...
United States United Kingdom San Francisco Zhi Li Junshi Biosciences Journal Of The American Medical Association

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer

SHANGHAI, China, Jan. 17, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading…
New York United States United Kingdom San Francisco Barbara Shecter Tiff Macklem

Junshi Biosciences Announces Approval of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Resectable NSCLC Patients

SHANGHAI, China, Jan. 02, 2024 -- Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of...
United Kingdom San Francisco United States Junshi Biosciences Zhi Li Shanghai Junshi Biosciences Co Ltd

Coherus and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Trial Evaluating LOQTORZI™ (toripalimab-tpzi) as Treatment for Nasopharyngeal Carcinoma, in the Journal of the American Medical Association

– Final overall survival analysis of the JUPITER-02 trial shows first-line treatment with LOQTORZI plus chemotherapy significantly prolongs survival in patients with recurrent or metastatic NPC...
United States Junshi Biosciences Judy Stecker Jami Taylor Coherus Biosciences Zhi Li

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science